The successful completion of the phase one deployment of TrakCare Lab is proof of NHLS’s capability to improve overall service delivery in the South African public healthcare sector
Cambridge, Mass.—September 27, 2010— InterSystems Corporation today announced that the National Health Laboratory Service in South Africa (NHLS) has successfully completed the first of two deployment phases for InterSystems TrakCare Lab™. The consolidated laboratory service is a key part of the Government’s programme to improve the management of pandemic and chronic illnesses, including HIV/AIDS and drug resistant tuberculosis, and the overall healthcare service delivery levels to the citizens of South Africa.
The NHLS handles all public health sector pathology testing and provides an extensive array of research and disease monitoring services designed to support the 4,000 clinics and 400hospitals in the South African public healthcare system. This system provides healthcare services for the approximately 38 million uninsured of the 45 million people in South Africa. NHLS supports the National Department of Health and employs 6,500 people at more than 250 laboratories throughout the country. The first phase has seen the full implementation in the 54 laboratories in KwaZuluNatal, a province on South Africa’s east coast which is the epicenter of the world’s HIV/AIDS epidemic.
TrakCare Lab is helping to reduce costs, improve productivity and quality of care, and significantly speed up the service levels to nearly forty thousand healthcare professionals working in the public healthcare system.
InterSystems has contributed to the South African government’s imperative of Black Economic Empowerment by providing training to and partnering with Health Systems Technologies (HST), a local black-owned company and a wholly owned subsidiary of the listed Sekunjalo Group. HST is the prime contractor and system integrator to the NHLS, supplying hardware, software and multiple services, including comprehensive skills transfer. HST has boosted local skills in project management, system integration, workflow optimization, technical services, implementation and training.
TrakCare Lab meets the operational needs of the modern pathology laboratory, with specific design that streamlines the laboratory disciplines and external referral work management. It supports laboratory professionals in processing and analysing results while also delivering those results to caregivers in easy-to-understand formats. The program is implementing TrakCare Lab on a network that utilizes InterSystems CACHÉ® high-performance object database as a centralised repository. It also uses InterSystems Ensemble®, a seamless platform for integration and the development of connectable applications, to enable smooth integration and connectivity for multiple applications and information repositories.
Sagie Pillay, CEO of NHLS said, “We have seen the need for pathology services increase by 106 percent over the last four years. With this ever-increasing demand for top-tier testing and disease monitoring services, it was essential to implement a world-class laboratory information management system (LIMS). We considered an extensive in-depth evaluation of leading LIMS products before concluding that the TrakCare Lab system is the optimal choice for NHLS.”
Joerg Klingler, InterSystems Group Managing Director, commented, “NHLS provides pathology services for the most vulnerable people in the patient population who are not covered by private insurance and must rely on the state for healthcare delivery. Implementing TrakCare Lab has made it possible for NHLS to reduce ongoing costs, increase overall productivity and job satisfaction, and most critically to improve the quality of care to those who need it most.
“This implementation is a major undertaking for South Africa and the health sector,” says Henry Adams, InterSystems Country Manager, “With the completion of the initial rollout of the system in KwaZuluNatal, NHLS is now considering phase two. InterSystems looks forward to delivering software for connected healthcare throughout the country. We are excited and grateful to have the opportunity to work with NHLS and HST on such an important initiative that directly contributes to the welfare of South Africa’s people.”
InterSystems Corporation is the worldwide leader in software for connected healthcare. With headquarters in Cambridge, Massachusetts, and offices in 25 countries, InterSystems provides advanced software technologies for breakthrough applications. InterSystems TrakCare™ is a Web-based healthcare information system that rapidly delivers the benefits of an Electronic Patient Record. InterSystems CACHÉ® is a high performance object database that makes applications faster and more scalable. InterSystems Ensemble® is a seamless platform for integration and the development of connectable applications. InterSystems HealthShare™ is a platform that enables the fastest creation of an Electronic Health Record for regional or national health information exchange. InterSystems DeepSee™ is software that makes it possible to embed real-time business intelligence capabilities in transactional applications.
InterSystems is the world’s #1 vendor of database and integration technologies for healthcare applications. InterSystems products are used by thousands of hospitals and labs worldwide, including all 14 hospitals on the Honor Roll of America’s Best Hospitals as rated by U.S. News and World Report. For more information, visit InterSystems.com.
The National Health Laboratory Service in South Africa (NHLS) is the largest laboratory network in Africa. The NHLS handles every pathology test in the public sector, serving a patient base of more than 38 million people—approximately 80 percent of South Africa’s total population. In addition to pathology testing and disease monitoring services, the NHLS is responsible for all pathology training and research in South Africa, working closely with medical schools and other learning and research institutes both domestically and throughout the world. The NHLS also conducts health-related research in areas such as HIV/AIDS, tuberculosis, malaria, and other infections, occupational health, cancer and malnutrition surveillance, appropriate to broader population needs. Its specialised division for the National Institute for Communicable Diseases is a major global influencer in infectious disease intelligence and plays a vital role in efforts to reduce risk of potentially pandemic diseases on an international scale.
Shoor & Company